CNS Open Data
Latest UpdatesOpen DatasetsClinical TrialsResearch GuidesTrend ReportsGlossaryData SourcesAbout
CNS Open Data— Open Science Portal for Central Nervous System Research|Research Guides|Trend Reports|Glossary|Ranking|Open Datasets|About|Privacy Policy
AlzforumOpenNeuroDANDI ArchiveAgora (AMP-AD)
Back to Research Playbooks & Guides
Disease Research PlaybookALS & Motor NeuronscRNA-seq

ALS & Motor Neuron Disease Open Data Guide: TDP-43 Cryptic Exons, NfL Trajectories & ENCALS Models

Integrating RNA-seq cryptic splicing datasets, plasma neurofilament biomarkers, and clinical survival endpoints.

CNS Open Data Editorial & Motor Neuron Research TeamUpdated: 2026-10-1511 min read
Executive Summary

Amyotrophic Lateral Sclerosis (ALS) exhibits extreme clinical variability, with survival ranging from under 18 months to over a decade. Recent open-science advances in TDP-43 cryptic exon biology (STMN2, UNC13A), antisense oligonucleotide (ASO) trials, and plasma Neurofilament Light Chain (NfL) pharmacodynamics have revolutionized ALS trial design. This guide covers best practices for analyzing open ALS transcriptomic, genetic, and clinical datasets.

Table of Contents

  1. 01.1. Detecting TDP-43 Loss-of-Function via Cryptic Exon Splicing
  2. 02.2. Clinical Trial Stratification: ALSFRS-R Slopes & Neurofilament Dynamics
  3. 03.Reproducible Python Starter Code
  4. 04.Governance & Reproducibility Checklist
SECTION 01

1. Detecting TDP-43 Loss-of-Function via Cryptic Exon Splicing

In ~97% of ALS cases, nuclear depletion of TDP-43 derepresses intronic cryptic exons in neuronal transcripts such as STMN2 (encoding Stathmin-2, essential for axonal regeneration) and UNC13A (critical for synaptic vesicle priming). Importantly, standard gene-level count matrices often miss cryptic splicing events because cryptic exons introduce premature stop codons that trigger nonsense-mediated decay (NMD). Secondary analysts re-processing open RNA-seq datasets should quantify junction-spanning reads (via LeafCutter, MAJIQ, or STAR splice junctions).
Key Practical Takeaways
  • Use junction-aware splicing tools (MAJIQ, LeafCutter) on high-depth RNA-seq to detect STMN2 and UNC13A cryptic exons.
  • Account for UNC13A risk SNPs (rs12608932) which potentiate cryptic exon inclusion upon TDP-43 depletion.
  • Benchmark clinical progression using the ENCALS multivariable survival model alongside ΔALSFRS-R and plasma NfL.
SECTION 02

2. Clinical Trial Stratification: ALSFRS-R Slopes & Neurofilament Dynamics

Because unstratified ALS trials suffer from high variance in natural history progression, the European Network to Cure ALS (ENCALS) established a validated prognostic model incorporating age at onset, diagnostic delay, baseline ALSFRS-R progression rate, forced vital capacity (FVC), bulbar onset, FTD comorbidity, and C9orf72 status. Pairing ENCALS risk profiles with log-transformed plasma NfL substantially reduces required trial sample sizes.

Python Example: Computing Pre-Baseline ALSFRS-R Progression Rate (ΔFS) & Log-NfL Stratification

Standard Python template ready for integration into local Jupyter notebooks or automated pipelines.

import numpy as np
import pandas as pd

def compute_als_progression_metrics(df: pd.DataFrame) -> pd.DataFrame:
    """
    Calculate pre-baseline progression slope (Delta-FS) and log10 plasma NfL
    for ALS clinical cohort stratification (ENCALS / PRO-ACT standard).
    """
    df = df.copy()
    # Delta-FS = (48 - ALSFRS_R_at_baseline) / diagnostic_delay_months
    df["delta_fs_slope"] = (48.0 - df["alsfrs_r_baseline"]) / df["months_since_symptom_onset"].clip(lower=1.0)
    df["log10_plasma_nfl"] = np.log10(df["plasma_nfl_pg_ml"].clip(lower=1.0))
    
    # Classify progression tier based on Delta-FS (Slow < 0.5, Intermediate 0.5-1.0, Fast > 1.0 pts/mo)
    df["progression_tier"] = pd.cut(
        df["delta_fs_slope"],
        bins=[-np.inf, 0.5, 1.0, np.inf],
        labels=["Slow (<0.5/mo)", "Intermediate (0.5-1.0/mo)", "Fast (>1.0/mo)"]
    )
    return df

Research Governance & Reproducibility Checklist

  • Separate bulbar-onset vs. spinal-onset ALS and genetic (SOD1, C9orf72, FUS, TARDBP) vs. sporadic cases.
  • Log-transform skewed fluid biomarkers (plasma/CSF NfL and pNfH) prior to parametric regression.
  • Use joint modeling of longitudinal ALSFRS-R and time-to-event survival (or CAFS) to handle informative dropout.

Key Biomarkers & Standards Referenced in This Guide

View Full Glossary
TDP-43
TAR DNA-Binding Protein 43 (TARDBP)

Nuclear RNA/DNA-binding protein whose cytoplasmic mislocalization, phosphorylation, and loss of nuclear splicing function drive >95% of ALS cases and ~50% of FTD.

Read entry
SOD1
Superoxide Dismutase 1 (Cu/Zn-SOD1)

Antioxidant enzyme gene; gain-of-toxicity mutations in SOD1 account for ~15-20% of familial ALS and are targeted by the approved antisense oligonucleotide Tofersen.

Read entry
C9orf72
Chromosome 9 Open Reading Frame 72 (GGGGCC Hexanucleotide Repeat)

Hexanucleotide repeat expansion (GGGGCC) in C9orf72 is the most common genetic cause of both familial ALS and familial frontotemporal dementia (FTD).

Read entry
NfL
Neurofilament Light Chain (Plasma / CSF NfL)

Axonal cytoskeletal protein released into CSF and blood upon neuroaxonal injury; a cross-disease biomarker of neurodegeneration rate in ALS, MS, AD, and FTD.

Read entry
ALSFRS-R
Revised Amyotrophic Lateral Sclerosis Functional Rating Scale

Gold-standard 48-point clinical rating scale assessing bulbar, fine motor, gross motor, and respiratory function in ALS clinical trials.

Read entry

Live Open Datasets & Papers Matching This Guide

Explore all matching resources
Allen Brain Map / BICCNBroad CNS / NeuroimagingOpen Dataset

BICCN Whole Human Brain Single-Cell Transcriptomic Cell Type Atlas

Cell atlas spanning >3 million single nuclei across 100+ human brain regions, mapping distinct vulnerable neuronal and glial sublineages.

Abstract / Summary
10x snRNA-seqMERFISH#Allen Brain Map#BICCN#scRNA-seq#Cell AtlasSample Size: 3.2 Million Nuclei
Sep 23, 2026
BICCN Consortium +1
Visit SourceDOI
View Details
bioRxiv (Neuroscience)Multiple SclerosisPreprint
Commercial Use Allowed - CC-BY 4.0

Spatial Transcriptomics of Chronic Active Multiple Sclerosis Lesions Reveals Iron-Laden MIMS Microglia Driving OPC Differentiation Arrest

Subcellular MERFISH and single-nucleus RNA sequencing across human post-mortem white matter lesions map complement C1q signaling and interferon-responsive oligodendrocyte states at paramagnetic lesion rims.

Abstract / Summary
MERFISHsnRNA-seq7T MRI#Multiple Sclerosis#MERFISH#scRNA-seq#PRL
Oct 20, 2026
Absinta M +3
Visit SourceDOI
View Details
DANDI ArchiveBroad CNS / NeuroimagingOpen Dataset
Commercial Use Allowed - CC-BY 4.0

Dandiset 000108: Single-Cell Patch-seq Electrophysiology and Morphometry of Human Neocortical Neurons

Over 1,200 human surgical neocortical pyramidal neurons and interneurons characterized with patch-clamp electrophysiology, morphological reconstruction, and scRNA-seq.

Abstract / Summary
Electrophysiology (NWB)MorphologyscRNA-seq#Patch-seq#NWB#Electrophysiology#Single CellSample Size: 1,240 Cells
Aug 21, 2026
Allen Institute for Brain Science +1
Visit SourceDOIData
View Details
medRxiv (Neurology)Parkinson's & MovementPreprint
Academic / Non-Commercial - cc_by_nc_nd

Peripheral Immune Alterations and T Cell Clonal Dynamics Across the Parkinson's Disease Spectrum

The role of peripheral immunity in Parkinsons disease (PD) remains incompletely understood. Here, we performed paired single-cell RNA sequencing (scRNA-seq) and T-cell receptor (TCR) profiling of 630k peripheral blood mononuclear cells (PBMCs) from 168 donors spanning idiopathic and genetic PD, prod...

Abstract / Summary
Clinical NeurologyPreprint Article#medRxiv Clinical#Clinical Neurology#genetic and genomic medicine#PARKINSON
Sep 29, 2026
Rosen, M. +4
Visit SourceDOIData
View Details
Allen Brain Map / BICCNAlzheimer's & DementiaOpen Dataset
Commercial Use Allowed - Allen Institute Terms of Use (Open Access / CC-BY)

Allen Brain Atlas: Aging Dementia TBI - non-ISH data

Neuropathologic, molecular and transcriptomic study of aging, dementia, and Traumatic Brain Injury (TBI) of brains from control and TBI cases in a unique aged population-based cohort from the Adult Changes in Thought (ACT) study. Non-ISH data.... Freely accessible open data product maintained by the Allen Institute for Brain Science.

Abstract / Summary
TranscriptomicsSpatial ISH#Allen Brain Map#Open Science#Human#Aging, Dementia and Traumatic Brain Injury (TBI)
Oct 22, 2026
Allen Institute for Brain Science +1
Visit SourceData
View Details
Allen Brain Map / BICCNBroad CNS / NeuroimagingOpen Dataset
Commercial Use Allowed - Allen Institute Terms of Use (Open Access / CC-BY)

Allen Brain Atlas: Non-Human Primate Macrodissection Microarray

Genome-wide microarray data profiling gene expression in gross brain structures using rhesus macaque-specific DNA microarrays.... Freely accessible open data product maintained by the Allen Institute for Brain Science.

Abstract / Summary
Transcriptomics#Allen Brain Map#Open Science#NHP#NIH Blueprint Non-Human Primate (NHP) Atlas
Oct 22, 2026
Allen Institute for Brain Science +1
Visit SourceData
View Details

More Research Playbooks & Tutorials

Disease Research Playbook

Alzheimer's Disease (AD) Open Data Guide: Integrating Neuroimaging (BIDS), Plasma Biomarkers & Multi-Omics

12 min read
Disease Research Playbook

Parkinson's Disease (PD) Open Data Guide: Alpha-Synuclein Assays, Basal Ganglia LFP & Cohort Harmonization

11 min read
Disease Research Playbook

Multiple Sclerosis (MS) Open Data Guide: Federated Real-World Data (OMOP CDM) & MRI Lesion Analysis

10 min read